Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Galapagos
Biotech
'Gilead wants us to rebuild': Why Galapagos can't go extinct
CEO Paul Stoffels has left, and his cell therapy strategy has been scrapped. So what happened to Galapagos?
James Waldron
Nov 19, 2025 7:50am
Galapagos to wind down cell therapy unit, threatening 365 jobs
Oct 21, 2025 9:30am
Ikena and Inmagene choose combined CEO—Chutes & Ladders
Jul 25, 2025 8:30am
Galapagos builds island of cell therapies amid pipeline pruning
Jul 24, 2025 10:59am
Galapagos gets cold feet over plans to split up company
May 13, 2025 6:55am
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Apr 25, 2025 8:30am